» Articles » PMID: 36661843

Optimized Ebselen-Based Inhibitors of Bacterial Ureases with Nontypical Mode of Action

Abstract

Screening of 25 analogs of Ebselen, diversified at the N-aromatic residue, led to the identification of the most potent inhibitors of urease reported to date. The presence of a dihalogenated phenyl ring caused exceptional activity of these 1,2-benzisoselenazol-3(2)-ones, with value in a low picomolar range (<20 pM). The affinity was attributed to the increased π-π and π-cation interactions of the dihalogenated phenyl ring with αHis323 and αArg339 during the initial step of binding. Complementary biological studies with selected compounds on the inhibition of ureolysis in whole cells showed a very good potency (IC < 25 nM in phosphate-buffered saline (PBS) buffer and IC < 50 nM in a urine model) for monosubstituted N-phenyl derivatives. The crystal structure of urease inhibited by one of the most active analogs revealed the recurrent selenation of the Cys322 thiolate, yielding an unprecedented Cys322-S-Se-Se chemical moiety.

Citing Articles

The effect of three urease inhibitors on viability, urease activity and urease gene expression.

Shaalan H, Azrad M, Peretz A Front Microbiol. 2024; 15:1464484.

PMID: 39619692 PMC: 11604635. DOI: 10.3389/fmicb.2024.1464484.


Targeted nanotherapeutics for the treatment of Helicobacter pylori infection.

Chitas R, Fonseca D, Parreira P, Martins M J Biomed Sci. 2024; 31(1):78.

PMID: 39128983 PMC: 11316987. DOI: 10.1186/s12929-024-01068-9.


4-Hydroxybenzoic Acid-Based Hydrazide-Hydrazones as Potent Growth Inhibition Agents of Laccase-Producing Phytopathogenic Fungi That Are Useful in the Protection of Oilseed Crops.

Maniak H, Matyja K, Plaskowska E, Jarosz J, Majewska P, Wietrzyk J Molecules. 2024; 29(10).

PMID: 38792074 PMC: 11124341. DOI: 10.3390/molecules29102212.


Ebselen: A Promising Repurposing Drug to Treat Infections Caused by Multidrug-Resistant Microorganisms.

Alves de Lima E Silva A, Rio-Tinto A Interdiscip Perspect Infect Dis. 2024; 2024:9109041.

PMID: 38586592 PMC: 10998725. DOI: 10.1155/2024/9109041.


Recent advances in DDAH1 inhibitor design and discovery: insights from structure-activity relationships and X-ray crystal structures.

Doman A, Perkins M, Tommasi S, Mangoni A, Nair P RSC Adv. 2024; 14(14):9619-9630.

PMID: 38525060 PMC: 10958460. DOI: 10.1039/d3ra08210e.


References
1.
Coker C, Poore C, Li X, Mobley H . Pathogenesis of Proteus mirabilis urinary tract infection. Microbes Infect. 2000; 2(12):1497-505. DOI: 10.1016/s1286-4579(00)01304-6. View

2.
Schewe T . Molecular actions of ebselen--an antiinflammatory antioxidant. Gen Pharmacol. 1995; 26(6):1153-69. DOI: 10.1016/0306-3623(95)00003-j. View

3.
Leroux F, Bosc D, Beghyn T, Hermant P, Warenghem S, Landry V . Identification of ebselen as a potent inhibitor of insulin degrading enzyme by a drug repurposing screening. Eur J Med Chem. 2019; 179:557-566. PMC: 6718346. DOI: 10.1016/j.ejmech.2019.06.057. View

4.
Silver L . A Gestalt approach to Gram-negative entry. Bioorg Med Chem. 2016; 24(24):6379-6389. DOI: 10.1016/j.bmc.2016.06.044. View

5.
Gustafsson T, Osman H, Werngren J, Hoffner S, Engman L, Holmgren A . Ebselen and analogs as inhibitors of Bacillus anthracis thioredoxin reductase and bactericidal antibacterials targeting Bacillus species, Staphylococcus aureus and Mycobacterium tuberculosis. Biochim Biophys Acta. 2016; 1860(6):1265-71. DOI: 10.1016/j.bbagen.2016.03.013. View